Cytosorbents Europe GmbH
Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
CytoSorb® in Patients With Acute on Chronic Liver Failure
- Conditions
- Acute on Chronic Liver FailureAlcoholic Hepatitis
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- CytoSorbents Europe GmbH
- Registration Number
- NCT05131230
- Locations
- 🇩🇪
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH, Bochum, Germany
🇩🇪University of Rostock, Rostock, Germany
A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock
- Conditions
- Septic Shock
- First Posted Date
- 2021-07-15
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- CytoSorbents Europe GmbH
- Target Recruit Count
- 260
- Registration Number
- NCT04963920
- Locations
- 🇩🇪
Department of Nephrology and Medical Intensive Care, Charité - University Medical Center, Berlin, Germany
🇩🇪Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪St. Josefs Hospital - Katholisches Klinikum Bochum, Bochum, Germany
Ticagrelor Removal Study Using CytoSorb® 300 mL Device During CPB in Patients Undergoing Emergent Cardiothoracic Surgery
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2020-11-12
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- CytoSorbents Europe GmbH
- Target Recruit Count
- 6
- Registration Number
- NCT04625764
- Locations
- 🇩🇪
University Hospital Essen, Essen, Germany
🇩🇪Asklepios Hospital St. Georg Hamburg, Hamburg, Germany
🇩🇪University Hospital Jena, Jena, Germany